Eli Lilly (LLY) earnings Q4 2025
Eli Lilly and Company’s logo is displayed during a press conference in Houston, Texas, US, Sept. 23, 2025. Antranik Tavitian | Reuters Eli Lilly on Wednesday posted fourth-quarter earnings and revenue and 2026 guidance that blew past estimates, as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro soars. The pharmaceutical giant…